Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIAID

Pvs28, A VACCINE CANDIDATE FOR BLOCKING TRANSMISSION OF PLASMODIUM VIVAX

  • Read more about Pvs28, A VACCINE CANDIDATE FOR BLOCKING TRANSMISSION OF PLASMODIUM VIVAX
US Application 60/045,283
Filed on 1997-05-01

Variant Peptide Ligands That Selectively Induce Apoptosis

  • Read more about Variant Peptide Ligands That Selectively Induce Apoptosis
US Application 60/072,952
Filed on 1998-01-29

METHODS OF USING CR3 AND CR4 LIGANDS FOR INHIBITING INTERLEUKIN-12 TO TREAT AUTOIMMUNE DISEASE

  • Read more about METHODS OF USING CR3 AND CR4 LIGANDS FOR INHIBITING INTERLEUKIN-12 TO TREAT AUTOIMMUNE DISEASE
US Application 60/066,238
Filed on 1997-11-20

PRODUCTION OF PARAINFLUENZA VIRUS FROM CLONED NUCLEOTIDE SEQUENCES

  • Read more about PRODUCTION OF PARAINFLUENZA VIRUS FROM CLONED NUCLEOTIDE SEQUENCES
US Application 60/047,575
Filed on 1997-05-23

STRL33, A NOVEL CHEMOKINE RECEPTOR-LIKE PROTEIN, FUNCTIONS AS A FUSION COFACTOR FOR BOTH MACROPHAGE-TROPIC AND T CELL LINE-TROPIC HIV-1

  • Read more about STRL33, A NOVEL CHEMOKINE RECEPTOR-LIKE PROTEIN, FUNCTIONS AS A FUSION COFACTOR FOR BOTH MACROPHAGE-TROPIC AND T CELL LINE-TROPIC HIV-1
US Application 60/042,880
Filed on 1997-03-31

Production of Attenuated Respiratory Syncytial Virus Vaccines From Cloned Nucleotide Sequences

  • Read more about Production of Attenuated Respiratory Syncytial Virus Vaccines From Cloned Nucleotide Sequences
US Application 60/021,773
Filed on 1996-07-15

METHOD FOR TREATING HUMAN IMMUNODEFICIENCY VIRUS INFECTION WITH IL-10

  • Read more about METHOD FOR TREATING HUMAN IMMUNODEFICIENCY VIRUS INFECTION WITH IL-10
US Application 60/021,670
Filed on 1996-07-05

PFS25-28 FUSION AS A MALARIA TRANSMISSION BLOCKING VACCINE

  • Read more about PFS25-28 FUSION AS A MALARIA TRANSMISSION BLOCKING VACCINE
US Application 60/027,390
Filed on 1996-09-30

CC CHEMOKINE RECEPTOR 5 DNA, NEW ANIMAL MODELS AND THERAPEUTIC AGENTS FOR HIV INFECTION

  • Read more about CC CHEMOKINE RECEPTOR 5 DNA, NEW ANIMAL MODELS AND THERAPEUTIC AGENTS FOR HIV INFECTION
US Application 60/018,508
Filed on 1996-05-28

SIMIAN-HUMAN HAV HAVING A CHIMERIC 2C PROTEIN CHIMERIC 2C PROTEIN

  • Read more about SIMIAN-HUMAN HAV HAVING A CHIMERIC 2C PROTEIN CHIMERIC 2C PROTEIN
US Application 60/015,642
Filed on 1996-04-19

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 108
  • Page 109
  • Page 110
  • Page 111
  • Page 112
  • Page 113
  • Page 114
  • Page 115
  • Page 116
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIAID
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health